BROOKE KUTKA: Open Payments
NPI 1841441805 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,653 in 107 payments from 19 companies in 2025. Trend: 2023 $22,201 · 2024 $9,728 · 2025 $5,653
Speaker / faculty: $3,500Food & beverage: $2,153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $4,129 |
| PFIZER INC. | 15 | $330 |
| Axsome Therapeutics, Inc. | 7 | $201 |
| Lundbeck LLC | 11 | $187 |
| Alexion Pharmaceuticals, Inc. | 6 | $142 |
| Biogen, Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Genentech USA, Inc. | 3 | $75 |
| UCB, Inc. | 2 | $58 |
| GENZYME CORPORATION | 3 | $56 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, Symbravo, VYEPTI, ULTOMIRIS, BOTOX, ZAVZPRET.
Industry payments across CA — which companies pay providers there.
